Review: could Metoprolol Tartrate cause Rectal Bleeding?


Summary

Rectal bleeding is found among people who take Metoprolol Tartrate, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Warfarin Sodium, and have High blood pressure . We study 39,532 people who have side effects while taking Metoprolol tartrate from FDA and social media. Among them, 35 have Rectal bleeding. Find out below who they are, when they have Rectal bleeding and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 46,723 users)

Rectal Bleeding

Rectal bleeding (bleeding from rectum) has been reported by people with campylobacter enteritis (latest reports from 3,095 Rectal bleeding patients).

On Sep, 16, 2016

39,532 people reported to have side effects when taking Metoprolol Tartrate.
Among them, 35 people (0.09%) have Rectal Bleeding


Number of reports submitted per year:

Could Metoprolol tartrate cause Rectal bleeding?

Time on Metoprolol Tartrate when people have Rectal Bleeding *:

  • < 1 month: 25 %
  • 1 - 6 months: 25 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 25 %
  • 10+ years: 0.0 %

Gender of people who have Rectal Bleeding when taking Metoprolol Tartrate *:

  • female: 48.57 %
  • male: 51.43 %

Age of people who have Rectal Bleeding when taking Metoprolol Tartrate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 2.94 %
  • 30-39: 8.82 %
  • 40-49: 8.82 %
  • 50-59: 8.82 %
  • 60+: 70.59 %

Severity if Rectal Bleeding when taking Metoprolol Tartrate **:

  • least: 20 %
  • moderate: 80 %
  • severe: 0.0 %
  • most severe: 0.0 %

How people recovered from Rectal Bleeding **:

  • while on drug: 0.0 %
  • after off the drug: 50 %
  • not yet: 50 %

Top conditions involved for these people *:

  • High Blood Pressure (4 people, 11.43%)
  • Urinary Tract Disorder (1 person, 2.86%)
  • Spinal Stenosis (1 person, 2.86%)
  • Sleep Apnoea Syndrome (1 person, 2.86%)
  • Postural Orthostatic Tachycardia Syndrome (1 person, 2.86%)

Top co-used drugs for these people *:

  • Warfarin Sodium (6 people, 17.14%)
  • Zocor (5 people, 14.29%)
  • Simvastatin (4 people, 11.43%)
  • Oxycontin (4 people, 11.43%)
  • Folic Acid (4 people, 11.43%)

Top other side effects for these people *:

  • Epistaxis (7 people, 20.00%)
  • Haemoglobin Decreased (6 people, 17.14%)
  • Haematocrit Decreased (6 people, 17.14%)
  • Gastrointestinal Haemorrhage Nos (6 people, 17.14%)
  • Diarrhoea Nos (6 people, 17.14%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Rectal bleeding when taking Metoprolol tartrate?

Browse all side effects of Metoprolol tartrate

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Rectal bleeding

Rectal bleeding

Could your condition cause Rectal bleeding

Rectal bleeding

Related studies

Can you answer these questions?

More questions for: Metoprolol tartrate, Rectal bleeding

You may be interested in these reviews

More reviews for: Metoprolol tartrate, Rectal bleeding


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.